ST. GALLEN, Switzerland — (BUSINESS WIRE) — Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma today announced full results from its phase-IIIb DIAMOND trial sh…
DIAMOND trial: Veltassa® enables patients to achieve long-term potassium control and optimized RAASi therapy
ST. GALLEN, Switzerland — (BUSINESS WIRE) — Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma today announced full results from its phase-IIIb DIAMOND trial sh…